Ohta S, Nishizawa S, Oki Y, Yokoyama T, Namba H
Department of Neurosurgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.
Pituitary. 2002;5(4):221-3. doi: 10.1023/a:1025321731790.
Biologically inactive ACTH-producing pituitary adenoma is known as clinically silent corticotroph adenoma. To search for the mechanism causing clinically silent corticotroph adenoma, we immunohistochemically examined the expression of prohormone convertase 1/3 (PC1/3) in this type of adenoma and compared our results with those obtained for Cushing's disease. All of the Cushing's disease specimens exhibited strongly positive PC1/3 exhibition. On the contrary, the expression of PC1/3 was very weak in the clinically silent corticotroph adenoma specimens. The absence of PC1/3 in clinically silent corticotroph adenoma indicates that silent corticotroph adenomas arise in a different cell type sharing the prohormone pro-opiomelanocortin (POMC), but processing it differently, accounting for the lack of clinical symptoms due to ACTH excess.
产生生物活性无促肾上腺皮质激素的垂体腺瘤被称为临床无功能性促肾上腺皮质激素腺瘤。为了探寻导致临床无功能性促肾上腺皮质激素腺瘤的机制,我们采用免疫组织化学方法检测了这类腺瘤中激素原转化酶1/3(PC1/3)的表达,并将结果与库欣病的检测结果进行比较。所有库欣病标本的PC1/3表达均呈强阳性。相反,临床无功能性促肾上腺皮质激素腺瘤标本中PC1/3的表达非常微弱。临床无功能性促肾上腺皮质激素腺瘤中PC1/3的缺失表明,无功能性促肾上腺皮质激素腺瘤起源于一种不同的细胞类型,该细胞类型共享激素原阿黑皮素原(POMC),但对其加工方式不同,这解释了为何不会因促肾上腺皮质激素过多而出现临床症状。